We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$44.4B
AUM Growth
+$4.56B
Cap. Flow
+$1.39B
Cap. Flow %
3.14%
Top 10 Hldgs %
19.07%
Holding
3,821
New
246
Increased
1,953
Reduced
1,330
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 12.61%
2 Financials 5.78%
3 Consumer Discretionary 5.1%
4 Healthcare 4.99%
5 Industrials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPH
3551
DELISTED
UpHealth, Inc.
UPH
$38K ﹤0.01%
1,703
+250
+17% +$5.79K
AGEN
3552
Agenus
AGEN
$249M
$37K ﹤0.01%
597
-556
-48% -$43.8K
OPTT icon
3553
Ocean Power Technologies
OPTT
$38.3M
$37K ﹤0.01%
25,114
+500
+2% +$974
RGLS
3554
DELISTED
Regulus Therapeutics
RGLS
$37K ﹤0.01%
11,900
+800
+7% +$3.56K
GNCA
3555
DELISTED
Genocea Biosciences, Inc.
GNCA
$37K ﹤0.01%
31,981
+10,576
+49% +$15.8K
EMX
3556
DELISTED
EMX Royalty
EMX
$36K ﹤0.01%
16,019
HIVE
3557
HIVE Digital Technologies
HIVE
$792M
$36K ﹤0.01%
2,764
-80
-3% -$1.38K
NEWP
3558
New Pacific Metals
NEWP
$833M
$36K ﹤0.01%
+12,260
New +$40K
DNN icon
3559
Denison Mines
DNN
$2.63B
$35K ﹤0.01%
26,043
+3,104
+14% +$5.09K
VGZ icon
3560
Vista Gold
VGZ
$253M
$35K ﹤0.01%
+50,000
New +$36.3K
GALT icon
3561
Galectin Therapeutics
GALT
$229M
$34K ﹤0.01%
16,902
+5,000
+42% +$14.3K
CRNT icon
3562
Ceragon Networks
CRNT
$194M
$33K ﹤0.01%
12,975
+1,615
+14% +$4.86K
GTBP icon
3563
GT Biopharma
GTBP
$11.7M
$33K ﹤0.01%
+368
New +$55.1K
PLX icon
3564
Protalix BioTherapeutics
PLX
$191M
$33K ﹤0.01%
+40,290
New +$42.2K
ADMA icon
3565
ADMA Biologics
ADMA
$1.92B
$32K ﹤0.01%
23,010
-2,000
-8% -$2.63K
REI icon
3566
Ring Energy
REI
$322M
$32K ﹤0.01%
14,400
-1,500
-9% -$4.64K
VEON icon
3567
VEON
VEON
$3.53B
$32K ﹤0.01%
+755
New +$36.8K
MTNB icon
3568
Matinas BioPharma
MTNB
$1.55M
$29K ﹤0.01%
580
-468
-45% -$25K
APTX
3569
DELISTED
Aptinyx Inc. Common Stock
APTX
$29K ﹤0.01%
+11,100
New +$26.7K
TMDI
3570
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$29K ﹤0.01%
47,966
-892
-2% -$1K
LOGC
3571
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$29K ﹤0.01%
12,908
+72
+0.6% +$244
CARM
3572
DELISTED
Carisma Therapeutics
CARM
$28K ﹤0.01%
1,721
-525
-23% -$10.6K
RDHL
3573
Redhill Biopharma
RDHL
$3.85M
$28K ﹤0.01%
11
-1
-8% -$4K
XWEL icon
3574
XWELL
XWEL
$8.87M
$28K ﹤0.01%
707
-55
-7% -$1.74K
TXMD icon
3575
TherapeuticsMD
TXMD
$23.8M
$27K ﹤0.01%
1,544
-20
-1% -$599

Similar funds

Commonwealth Equity Services's Q4 2021 Portfolio in Review

As of Q4 2021, Commonwealth Equity Services held 3,821 positions worth $44.4B, up 11% from $39.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services deployed $1.39B of net new capital in Q4 2021, opening 246 new positions and adding to 1,953 existing holdings. Its largest new stake was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Gold Trust, an estimated $27.2M trimmed.

  • Commonwealth Equity Services's largest Q4 2021 buy was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.
  • Commonwealth Equity Services added most to iShares ESG Aware MSCI USA ETF in Q4 2021, an estimated $54M increase.
  • Commonwealth Equity Services's biggest Q4 2021 reduction was iShares Gold Trust, cutting an estimated $27.2M.
  • Commonwealth Equity Services fully exited PIMCO Dynamic Credit and Mortgage Income Fund in Q4 2021, selling an estimated $9.53M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $44.4B portfolio in Q4 2021.
  • Commonwealth Equity Services opened 246 new positions and closed 177 in Q4 2021.
  • Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $44.4B.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.